Conversely, in chemoresistant NSCLC, we identified the novel mechanism that Akt in turn promotes the function of EGFR via a positive feedback loop, leading to the suppression of ROS production and chemoresistance. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.